Venus Remedies Share Price (VENUSREM)
as on
| Source : NSE
Venus Remedies Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's High
₹510₹5120.39%
Upside
52 Week's Low
52 Week's High
₹270.25₹567.8
47.01%
Downside
11.33%
Upside
| Market Stats | |
| Previous Close | ₹502.00 |
| Open | ₹510.00 |
| Volume | 15.86K |
| Upper Circuit | ₹512.00 |
| Lower Circuit | ₹492.00 |
| Day's Low | ₹510 |
| Day's High | ₹512 |
| 52 Week Low | ₹270.25 |
| 52 Week High | ₹567.8 |
| Returns % | |
| 1 Month Return | -5.42 % |
| 3 Month Return | + 41.39 % |
| 1 Year Return | + 40.6 % |
| 3 Year Return | + 133.05 % |
| 5 Year Return | + 360.97 % |
Venus Remedies Stock Fundamentals & Key Indicators
Check Venus Remedies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹671.02 Cr
Return on Equity (ROE)
8.1
PE Ratio (TTM)
12.49
Return on capital employed (ROCE)
11.75
Industry PE ratio
43.37
Beta (LTM)
0.91
P/B Ratio
0.68
Dividend Yield
0PEG Ratio
0.66
Quarterly Earnings Growth YOY
686.89
EPS (TTM)
33.9
Sector
Pharmaceuticals
Book Value
419.65
Technical Analysis
Bullish
View Technical Analysis
Venus Remedies Stock's Interest Amongst Investors
Venus Remedies Stock Valuation
Track how Venus Remedies P/E has moved over time to understand its valuation trends.
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (12.49x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (21.70x)
December 28, 2023
Today’s Price to Earnings Ratio: 12.49x
Venus Remedies Ltd Financial Results
Get the annual and quarterly financial summary of Venus Remedies Ltd, including revenue, profit, loss and more.
Venus Remedies Earnings and Dividends
View detailed summary of the earnings and dividend history of Venus Remedies.
Venus Remedies Ltd Earnings Results
Venus Remedies Ltd’s net profit jumped 686.89% since last year same period to ₹9.60Cr in the Q1 2025-2026. On a quarterly growth basis, Venus Remedies Ltd has generated -54.29% fall in its net profits since last 3-months.
Read More about Earnings ResultsVenus Remedies Ltd Dividends May,2013
In the quarter ending March 2013, Venus Remedies Ltd has declared dividend of ₹3.00 per share on 20 May 2013 - translating a dividend yield of 1.20%.
Read More about Dividends
Venus Remedies Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Venus Remedies.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 41.76% | 0.00 | |
| Foreign Institutions | 2.24% | 67.49 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 55.89% | ||
| Others | 0.11% | 0.00 |
Venus Remedies Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 671.02 | 72.19% | 0.50 | 45 | 647 | |
| NA | 144.70 | 17.83% | 0.84 | 7 | 339 | |
| NA | 509.12 | 22.09% | 0.00 | NA | NA | |
| NA | 732.08 | 31.15% | 0.51 | 421 | 1,280 | |
| NA | 6.03 | -7.89% | 0.00 | -6 | NA |
Venus Remedies News & Key Events
Latest news and events in one place to help you make informed investing decisions in Venus Remedies.
Venus Remedies Drug Fails Quality Tests - 26 Jun, 2025
Venus Remedies' chemotherapy drug cyclophosphamide failed quality tests, with one sample containing only 26% of the required dose. Despite this, the drug has been shipped to six countries, including Ethiopia.Venus Remedies Reports Strong Financial Growth - 28 May, 2025
Venus Remedies reported a 10.78% increase in standalone net sales to Rs 194.04 crore for March 2025. Net profit rose 18.18% to Rs 14.79 crore, while EBITDA increased by 16.35%. The EPS also improved to Rs 11.07. The stock has delivered significant returns of 32.43% over the last six months and 35.50% over the past year.
Insights on Venus Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, VENUSREM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 3 months, VENUSREM stock has moved up by 41.4%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.34% to 2.24% in Jun 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 5.8%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 201.73 Cr → 140.59 Cr (in ₹), with an average decrease of 30.3% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 56.90% to 55.89% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 21.0 Cr → 9.6 Cr (in ₹), with an average decrease of 54.3% per quarter
About Venus Remedies Ltd
Revenue: ₹131.90Cr as on June 2025 (Q1 FY26)
Net Profit: ₹9.60Cr as on June 2025 (Q1 FY26)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
| Organisation | Venus Remedies Ltd |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| CEO | Pawan Chaudhary |
| E-voting on shares | Click here to vote |
FAQs
What is Venus Remedies share price today?
Venus Remedies share price today stands at ₹510, Open: ₹510, Previous Close: ₹502, High: ₹512, Low: ₹510, 52 Week High: ₹567.8, 52 Week Low: ₹270.25 as on .
How to buy Venus Remedies shares ?
To buy Venus Remedies shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for VENUSREM or Venus Remedies Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Venus Remedies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Venus Remedies?
Today's traded volume of Venus Remedies is 15.86K. Which means that 15.86K shares of Venus Remedies were bought and sold on the stock market during today's trading session.
What is Venus Remedies's market cap today?
Today's market capitalisation of Venus Remedies is ₹671.02 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Venus Remedies?
Venus Remedies’s 52 week high is ₹567.8 and 52 week low is ₹270.25. The current share price of Venus Remedies is ₹510, which is -10.18% down from its 52 week high and 88.71% up from its 52 week low.